Recruiting NCT06754514
Organ Retractor Device Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: liver retraction.
- Who it may be relevant to
- Registry conditions: Liver Retraction During Bariatric Surgery. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Boehringer Laboratories Organ Retractor Device Study
Overview
This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.
Interventions
- Device liver retraction
A different way to lift the liver during bariatric surgery
Primary outcome measures
- Ease of use and Feasibility [Time frame: During surgery]
Eligibility criteria
Inclusion criteria
- undergoing minimally invasive primary bariatric surgery
Exclusion criteria
- known liver disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
United States · 1 center
- WakeMed Health & Hospitals — Raleigh
Identifiers
NCT: NCT06754514 · Retractor-01